Protara Therapeutics Inc (TARA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $155.77M
Last updated: Nov 17, 2026 at 11:06 AM ET
Protara Therapeutics Inc (TARA) Competitors
The companies most similar to Protara Therapeutics are Compass Therapeutics (CMPX), Rocket Pharmaceuticals (RCKT) and Fate Therapeutics (FATE). By market cap, Protara Therapeutics ranks 8th of the 13 companies on this page; Larimar Therapeutics (LRMR) is the largest at $313.73M.
Peer Comparison
TARA's revenue growth of 0.0% is below the peer median of 7.9%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Protara Therapeutics (TARA) | $155.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Compass Therapeutics Inc. (CMPX) | $139.35M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rocket Pharmaceuticals Inc (RCKT) | $256.82M | N/A | N/A | 0.0% | -2.3% | 0.0% | 0.00% |
| Fate Therapeutics Inc (FATE) | $155.74M | N/A | 29.7x | 0.0% | -51.3% | 9.2% | 0.00% |
| Keros Therapeutics Inc (KROS) | $202.13M | N/A | 4.9x | -151.4% | N/A | 180.5% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| PDS Biotechnology Corp (PDSB) | $107.07M | N/A | N/A | 0.0% | -149.8% | 0.0% | 0.00% |
| Armata Pharmaceuticals Inc (ARMP) | $143.94M | N/A | 14.7x | 0.0% | -184.6% | 173.6% | 0.00% |
| Larimar Therapeutics Inc (LRMR) | $313.73M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| Arcturus Therapeutics Holdings Inc (ARCT) | $240.96M | N/A | 7.7x | -285.9% | N/A | 6.7% | 0.00% |
| Zentalis Pharmaceuticals Llc (ZNTL) | $167.05M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Innate Pharma (IPHA) | $154.15M | N/A | 17.6x | 0.0% | 489.8% | 16.5% | 0.00% |
| Peer median | $169.32M | N/A | 14.7x | 0.0% | -51.3% | 7.9% | 0.00% |
Similar Companies
These are the 12 companies most similar to Protara Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Compass Therapeutics Inc. (CMPX) | Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple... | CMPX competitors |
| Rocket Pharmaceuticals Inc (RCKT) | Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. | RCKT competitors |
| Fate Therapeutics Inc (FATE) | Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally. | FATE competitors |
| Keros Therapeutics Inc (KROS) | Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery... | KROS competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| PDS Biotechnology Corp (PDSB) | PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. | PDSB competitors |
| Armata Pharmaceuticals Inc (ARMP) | Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of specific bacteriophage therapies for the treatment... | ARMP competitors |
| Larimar Therapeutics Inc (LRMR) | Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. | LRMR competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| Arcturus Therapeutics Holdings Inc (ARCT) | Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. | ARCT competitors |
| Zentalis Pharmaceuticals Llc (ZNTL) | Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment... | ZNTL competitors |
| Innate Pharma (IPHA) | Innate Pharma SA, a biotechnology company, discovers, develops and markets therapeutic antibodies for the treatment of oncological indications in France... |
Frequently Asked Questions About TARA
Who are Protara Therapeutics' main competitors?
The companies most similar to Protara Therapeutics include Compass Therapeutics (CMPX), Rocket Pharmaceuticals (RCKT), Fate Therapeutics (FATE), Keros Therapeutics (KROS) and Prelude Therapeutics (PRLD), listed from the closest match.
Who is Protara Therapeutics' biggest competitor?
Larimar Therapeutics (LRMR) is the largest of the similar companies at $313.73M; Compass Therapeutics (CMPX) is the closest match by business profile, size, sector and industry.
How does TARA stock compare with its competitors?
TARA's net margin is 0.0% against a peer median of 0.0%.
Which of Protara Therapeutics' competitors pays a higher dividend?
Protara Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Protara Therapeutics bigger than its competitors?
No. Protara Therapeutics is 8th by market cap among the 13 companies on this page; the largest is Larimar Therapeutics (LRMR) at $313.73M.
TARA pages: Overview, Earnings, Forecast, Financials, Competitors